Cadence Bancorporation Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Cadence Bancorporation Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 |
---|---|---|---|---|---|---|
cash flows from operating activities | 40,035,000 | 78,014,000 | -9,953,000 | 55,219,000 | 409,335,000 | |
cash flows from investing activities | ||||||
purchase of securities available-for-sale | -589,065,000 | -970,633,000 | -702,378,000 | -837,810,000 | -264,922,000 | -240,734,000 |
proceeds from sales of securities available-for-sale | 5,316,000 | 118,697,000 | 62,850,000 | 45,697,000 | 142,721,000 | 37,884,000 |
proceeds from maturities, calls and paydowns of securities available-for-sale | 240,327,000 | 255,332,000 | 392,798,000 | 222,495,000 | 114,548,000 | 113,400,000 |
sales (purchases) of other securities | ||||||
proceeds from sales of loans transferred to held for sale | ||||||
decrease (increase) in loans | 666,585,000 | 355,420,000 | ||||
purchase of premises and equipment | -6,117,000 | -5,335,000 | -4,504,000 | -5,185,000 | -2,578,000 | -2,742,000 |
proceeds from disposition of foreclosed property | 1,600,000 | 10,000 | 224,000 | 976,000 | 905,000 | 1,182,000 |
other | -11,938,000 | 15,012,000 | 14,221,000 | -956,000 | -7,356,000 | -1,871,000 |
net cash from investing activities | 385,753,000 | -231,497,000 | 491,139,000 | -352,719,000 | -338,682,000 | -483,347,000 |
cash flows from financing activities | ||||||
increase in deposits | -145,391,000 | 76,954,000 | 266,024,000 | -283,061,000 | ||
repayment of senior debt | ||||||
repayment of subordinated debt | 0 | -40,000,000 | ||||
repurchase of common stock | 0 | -29,995,000 | 0 | -165,000 | 0 | -29,973,000 |
cash dividends paid on common stock | -18,816,000 | -18,904,000 | -9,450,000 | -6,299,000 | -6,296,000 | -22,139,000 |
net cash from financing activities | -214,207,000 | -11,945,000 | 256,576,000 | -289,525,000 | 1,573,481,000 | -305,401,000 |
net increase in cash and cash equivalents | 806,774,000 | -652,197,000 | ||||
cash and cash equivalents at beginning of period | 0 | 2,053,946,000 | 0 | 0 | 0 | 988,764,000 |
cash and cash equivalents at end of period | 211,581,000 | 1,888,518,000 | 806,774,000 | -652,197,000 | 1,290,018,000 | 609,351,000 |
supplemental disclosures | ||||||
cash paid during the period for: | ||||||
interest | 13,170,000 | 10,418,000 | 15,085,000 | 26,582,000 | 39,487,000 | |
income taxes paid | 78,409,000 | |||||
cash paid for amounts included in lease liabilities | 2,778,000 | 2,798,000 | 2,804,000 | 2,795,000 | 2,767,000 | |
non-cash investing activities | ||||||
acquisition of real estate and other assets in settlement of loans | 833,000 | 10,000 | 8,009,000 | 1,503,000 | 11,162,000 | |
transfers of loans held for sale to loans | 2,163,000 | 175,000 | 974,000 | 0 | 10,500,000 | |
transfers of loans to loans held for sale | 72,380,000 | 3,208,000 | ||||
securities (purchased) sold, net, with settlement after quarter end | 16,734,000 | -33,526,000 | ||||
right-of-use assets obtained in exchange for operating lease liabilities | ||||||
purchases of other securities | 205,000 | -32,000 | -574,000 | |||
net decrease in cash and cash equivalents | -165,428,000 | -379,413,000 | ||||
income taxes paid (refunded) | 2,000 | |||||
right-of-use assets obtained (remeasured) in exchange for operating lease liabilities | 4,145,000 | |||||
net income | ||||||
adjustments to reconcile net income to net cash from operations: | ||||||
net, depreciation and amortization | ||||||
goodwill impairment charge | ||||||
termination (purchase) of interest rate collar | ||||||
hedge revenue | ||||||
deferred income tax (benefit) expense | ||||||
benefit from credit losses | ||||||
(gain) loss on sale of securities | ||||||
gain on sale of insurance subsidiary assets | ||||||
gain on sale of loans | ||||||
proceeds from paydowns and sales of loans held for sale | ||||||
origination of loans held for sale | ||||||
increase in interest receivable | ||||||
increase in other assets | ||||||
increase in other liabilities | ||||||
net cash from operating activities | ||||||
cash received in acquisitions | ||||||
proceeds from sale of insurance subsidiary assets | ||||||
net change in short-term borrowings | ||||||
issuance of subordinated debentures | ||||||
proceeds from long term fhlb advances | ||||||
proceeds from sales of loans held for sale | 1,714,000 | 152,000 | 46,866,000 | |||
increase in loans | 220,145,000 | -322,120,000 | -436,758,000 | |||
net change in securities sold under agreements to repurchase | ||||||
net change in short term fhlb advances | ||||||
right-of-use assets (remeasured) obtained in exchange for operating lease liabilities | 11,000 | 504,000 | -125,000 | |||
advances on line of credit | ||||||
securities purchased, net, with settlement after quarter end | ||||||
decrease in deposits | -253,289,000 | |||||
income taxes (refunded) paid | -234,000 | |||||
securities sold, net, with settlement after quarter end | 57,157,000 |
We provide you with 20 years of cash flow statements for Cadence Bancorporation stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Cadence Bancorporation stock. Explore the full financial landscape of Cadence Bancorporation stock with our expertly curated income statements.
The information provided in this report about Cadence Bancorporation stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.